Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium
- PMID: 19059791
- DOI: 10.1016/j.biologicals.2008.11.001
Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium
Abstract
The recombinant G glycoprotein from the surface of the rabies virus (RVGP) is a promising candidate as a rabies vaccine component and also for diagnostic purposes. In this study, RVGP production by transfected Drosophila melanogaster S2 cells cultivated in a serum-free medium (supplemented IPL-41 medium) was carried out. The effects of pH and pO(2) were evaluated in batch culture in parallel spinner flasks. The use of a pH equal to 6.3 and a pO(2) of 40% air saturation resulted in the highest RVGP content. These conditions were also used in fed-batch mode, yielding a RVGP content level of 98g/10(7) cells. The main nutrients consumed were glucose, glutamine, asparagine, serine and proline and the major metabolites produced were alanine and ammonia, according to the metabolism studies performed. Since RVGP is a transmembrane protein, two different methods for protein recovery were assessed and compared. Detergent-based cell disruption showed to be more effective than mechanical disruption with glass beads for glycoprotein recovery.
Similar articles
-
Behavior of wild-type and transfected S2 cells cultured in two different media.Appl Biochem Biotechnol. 2011 Jan;163(1):1-13. doi: 10.1007/s12010-010-8918-z. Epub 2010 Dec 15. Appl Biochem Biotechnol. 2011. PMID: 21161610
-
Recombinant rabies virus glycoprotein synthesis in bioreactor by transfected Drosophila melanogaster S2 cells carrying a constitutive or an inducible promoter.J Biotechnol. 2010 Apr 15;146(4):169-72. doi: 10.1016/j.jbiotec.2010.02.011. Epub 2010 Feb 20. J Biotechnol. 2010. PMID: 20176061
-
Culture of transgenic Drosophila melanogaster Schneider 2 cells in serum-free media based on TC100 basal medium.Biotechnol J. 2007 Nov;2(11):1399-407. doi: 10.1002/biot.200700048. Biotechnol J. 2007. PMID: 17582824
-
Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development.Biotechnol Adv. 2012 May-Jun;30(3):613-28. doi: 10.1016/j.biotechadv.2011.10.009. Epub 2011 Nov 4. Biotechnol Adv. 2012. PMID: 22079894 Review.
-
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.Expert Rev Vaccines. 2009 May;8(5):607-18. doi: 10.1586/erv.09.19. Expert Rev Vaccines. 2009. PMID: 19397417 Review.
Cited by
-
Drosophila as a Model for Human Viral Neuroinfections.Cells. 2022 Aug 29;11(17):2685. doi: 10.3390/cells11172685. Cells. 2022. PMID: 36078091 Free PMC article. Review.
-
Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa.Virol J. 2019 Dec 30;16(1):167. doi: 10.1186/s12985-019-1263-0. Virol J. 2019. PMID: 31888686 Free PMC article. Review.
-
Kinetic studies of recombinant rabies virus glycoprotein (RVGP) cDNA transcription and mRNA translation in Drosophila melanogaster S2 cell populations.Cytotechnology. 2013 Oct;65(5):829-38. doi: 10.1007/s10616-012-9522-6. Epub 2013 Jan 23. Cytotechnology. 2013. PMID: 23340966 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources